Raising high density lipoprotein cholesterol: The biochemical pharmacology of reverse cholesterol transport
- 1 August 1990
- journal article
- editorial
- Published by Elsevier in Biochemical Pharmacology
- Vol. 40 (3) , 403-410
- https://doi.org/10.1016/0006-2952(90)90536-t
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Pathophysiology of reverse cholesterol transport. Insights from inherited disorders of lipoprotein metabolism.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1989
- High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.Circulation, 1989
- On the associations of body cholesterol pool size with age, HDL cholesterol and plasma total cholesterol concentration in humansAtherosclerosis, 1987
- Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study.Circulation, 1987
- High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial.Circulation, 1986
- The anatomy and physiology of reverse cholesterol transportClinical Science, 1986
- The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study.Circulation, 1984
- Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery DiseaseNew England Journal of Medicine, 1982
- A-IMilano apoprotein. Decreased high density lipoprotein cholesterol levels with significant lipoprotein modifications and without clinical atherosclerosis in an Italian family.Journal of Clinical Investigation, 1980
- Coronary Heart Disease Prevalence and Other Clinical Features in Familial High-Density Lipoprotein Deficiency (Tangier Disease)Annals of Internal Medicine, 1980